These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31261736)

  • 1. Sex- and Age-Related Estrogen Signaling Alteration in Inflammatory Bowel Diseases: Modulatory Role of Estrogen Receptors.
    Jacenik D; Cygankiewicz AI; Mokrowiecka A; Małecka-Panas E; Fichna J; Krajewska WM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.
    Linares PM; Algaba A; Urzainqui A; Guijarro-Rojas M; González-Tajuelo R; Garrido J; Chaparro M; Gisbert JP; Bermejo F; Guerra I; Castellano V; Fernández-Contreras ME
    Dig Dis Sci; 2017 Oct; 62(10):2744-2754. PubMed ID: 28823012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome.
    Jacenik D; Cygankiewicz AI; Fichna J; Mokrowiecka A; Małecka-Panas E; Krajewska WM
    Mol Cell Endocrinol; 2018 Aug; 471():89-96. PubMed ID: 28774781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled estrogen receptor mediates anti-inflammatory action in Crohn's disease.
    Jacenik D; Zielińska M; Mokrowiecka A; Michlewska S; Małecka-Panas E; Kordek R; Fichna J; Krajewska WM
    Sci Rep; 2019 May; 9(1):6749. PubMed ID: 31043642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis.
    Jacenik D; Beswick EJ; Krajewska WM; Prossnitz ER
    World J Gastroenterol; 2019 Aug; 25(30):4092-4104. PubMed ID: 31435166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomic Profiling in Inflammatory Bowel Disease: Comparison Between Ulcerative Colitis and Crohn's Disease.
    Fan F; Mundra PA; Fang L; Galvin A; Moore XL; Weir JM; Wong G; White DA; Chin-Dusting J; Sparrow MP; Meikle PJ; Dart AM
    Inflamm Bowel Dis; 2015 Jul; 21(7):1511-8. PubMed ID: 25895111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
    Zhang Z; Zhao X; Lv C; Li C; Zhi F
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G Protein-Coupled Receptor 30 (GPR30) Expression Pattern in Inflammatory Bowel Disease Patients Suggests its Key Role in the Inflammatory Process. A Preliminary Study.
    Włodarczyk M; Sobolewska-Włodarczyk A; Cygankiewicz AI; Jacenik D; Piechota-Polańczyk A; Stec-Michalska K; Krajewska WM; Fichna J; Wiśniewska-Jarosińska M
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):29-35. PubMed ID: 28338111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.
    Soletti RC; Rodrigues NA; Biasoli D; Luiz RR; de Souza HS; Borges HL
    PLoS One; 2013; 8(8):e70786. PubMed ID: 23967107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
    Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
    Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
    Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
    Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
    Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs).
    Vadasz Z; Rainis T; Nakhleh A; Haj T; Bejar J; Halasz K; Toubi E
    PLoS One; 2015; 10(5):e0125860. PubMed ID: 25978359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
    Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
    J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking estrogen receptor β expression with inflammatory bowel disease activity.
    Pierdominici M; Maselli A; Varano B; Barbati C; Cesaro P; Spada C; Zullo A; Lorenzetti R; Rosati M; Rainaldi G; Limiti MR; Guidi L; Conti L; Gessani S
    Oncotarget; 2015 Dec; 6(38):40443-51. PubMed ID: 26497217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.